Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases.
Giovanni Mario PesGian Luca ErreJessica PirodduGiovanni Mario PesPublished in: Helicobacter (2023)
According to our findings, patients with RA should benefit from being screened and eventually treated for H. pylori infection.
Keyphrases
- helicobacter pylori infection
- rheumatoid arthritis
- helicobacter pylori
- cardiovascular disease
- disease activity
- ankylosing spondylitis
- interstitial lung disease
- systemic lupus erythematosus
- type diabetes
- cardiovascular risk factors
- newly diagnosed
- metabolic syndrome
- idiopathic pulmonary fibrosis
- cardiovascular events